C44.711
Basal cell carcinoma of skin of unspecified lower limb, including hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Basal cell carcinoma (BCC) is the most common form of skin cancer, originating from the basal cells in the outermost layer of the skin. When it occurs on the lower limb, including the hip region, it typically appears as a slow-growing lesion. While BCC rarely spreads to other parts of the body, it can cause significant local tissue damage if not diagnosed and treated early. The ICD-10 code C44.711 specifically refers to basal cell carcinoma of the skin located on an unspecified part of the lower limb, including the hip.
Causes & Symptoms
Clinical Causes: Chronic exposure to ultraviolet (UV) radiation from the sun or tanning beds. Having a fair skin complexion that is more sensitive to UV damage. A history of sunburns, especially in early life. Genetic predisposition or family history of skin cancer. Prolonged exposure to certain chemicals or radiation. Weakened immune system, which may impair skin’s ability to repair damage.
Key Symptoms: A shiny, pearly bump that may be translucent or pink in color. An open sore that bleeds, oozes, or crusts and persists for weeks. A scar-like area that is slightly raised and appears translucent or waxy. Lesion with irregular borders that does not heal or frequently recurs. Sometimes associated with redness or inflammation around the lesion. May be asymptomatic in early stages, meaning it does not cause pain or discomfort.
Diagnostic & Treatment
Diagnosis Path: Diagnosis often begins with a thorough physical examination where healthcare providers inspect the skin for suspicious lesions. If a lesion appears characteristic of basal cell carcinoma, a biopsy is typically performed. During a biopsy, a small sample of tissue is removed from the lesion and examined under a microscope to confirm the diagnosis. Additional imaging tests may be used if there is a concern that the cancer has spread, although this is rare with BCC. Precise identification of the tumor’s size, depth, and location helps inform treatment planning.
Treatment Protocols: Treatment options for basal cell carcinoma of the lower limb include several approaches, depending on the size, location, and individual patient factors: - **Surgical excision:** The lesion is removed with a margin of healthy tissue to reduce recurrence risk. - **Mohs micrographic surgery:** A precise surgical method where layers of cancer-containing skin are progressively removed and examined until only cancer-free tissue remains, often used for lesions in cosmetically sensitive or challenging areas. - **Cryotherapy:** Freezing the lesion with liquid nitrogen, suitable for smaller, superficial BCCs. - **Topical therapies:** Such as imiquimod cream or 5-fluorouracil, used for superficial BCCs. - **Radiation therapy:** May be an option if surgery is not feasible or the patient cannot tolerate it. Follow-up care is vital to monitor for recurrence or new lesions, especially in individuals with high sun exposure or other risk factors.
Clinical Advice & FAQs
Billing Guidance
Is C44.711 a billable ICD-10 code?
Yes, C44.711 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C44.711?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of unspecified lower limb, including hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference